Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2014 ACR/ARHP Annual Meeting: Immunology Update on Innate Lymphoid Cells

Mary Beth Nierengarten  |  Issue: March 2015  |  March 1, 2015

Of importance is that the composition of ILCs depends on the tissue in which they are found, he said. Example: NKp44+ ILC2s are the most abundant ILCs in the ileum, and ILC2s are most abundant in the blood.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
click for large version

Human diseases may occur when the composition of these ILC subsets changes. Example: When looking at the gut, he said, the interaction of stromal cells and the cytokine, IL-22, provides a number of protections in the healthy gut: ILC3s derived under the influence of IL-22 protect against colitis and are critical for wound healing, and ILC3s favor growth of intestinal stem cells, and, in the mouse gut, dampen activation of pathogenic Th17 cells and, therefore, demonstrate protective immunity.

However, when the gut is inflamed, the composition of ILCs changes. Example: In patients with Crohn’s disease, ILC3s produce excessive amounts of IL-17, and ILC1s produce excessive amounts of IFNγ, both of which disturb homeostasis equilibrium and are important factors in the development of inflammation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

According to Dr. Spits, which phenotypes of human mucosal ILC develop depends on environmental cues. The plasticity of ILCs permits them to quickly switch between “harmless homeostasis and infectious states.”

Table 2 (above) lists changes in ILC composition in other organs/disease states.

“The better we understand this field, the more easily we can understand the medical literature and the therapeutics sure to arrive in the coming years,” said Dr. Sigal, adding that current research is exploring how the innate immune mechanisms may fuel the fires of chronic diseases.


Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

Key References

  • Spits H, Artis D, Colonna M, et al. Innate lymphoid cells—A proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145–149.
  • Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5):700–709.
  • Dienfenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity. 2014;41(3):354–365.
  • McKenzie AN, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity. 2014;41(3):366–374.

Second Chance

If you missed this session, ACR Immunology Update: Innate Lymphoid Cells, it’s not too late. Catch it on SessionSelect: http://acr.peachnewmedia.com/store/provider/provider09.php.

Page: 1 2 | Single Page
Share: 

Filed under:Meeting Reports Tagged with:ACR/ARHP Annual MeetingImmunologyNierengartenRheumatic Disease

Related Articles

    New Tech Provides Insights Into the Pathogenesis of Psoriatic Arthritis

    May 5, 2022

    The etiology of psoriatic arthritis (PsA) is poorly understood but current evidence supports an interaction between genetic and environmental factors that coalesce to promote local tissue inflammation.1-3 The pivotal cytokines that underlie the local inflammatory response in a wide range of tissues are interleukin (IL) 23, IL-17 and tumor necrosis factor (TNF).4 The central contribution…

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

    January 1, 2010

    A perspective on B cell–targeted therapies in autoimmune disease

    2014 ACR/ARHP Annual Meeting: Microbiota Power

    March 1, 2015

    Gut bacteria may hold clues to breakthrough rheumatic disease treatments

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences